Lotus Pharm vs Tien Liang Biotech: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Tien Liang Biotech (4127) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Tien Liang Biotech

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYTien Liang BiotechYoY
Oct 2026NT$2.13 billion-22.5%NT$44.1 million+2.3%
Sep 2026NT$2.77 billion+128.0%NT$57 million+10.9%
Aug 2026NT$2.11 billion+81.7%NT$54.8 million+40.8%
Jul 2026NT$2.49 billion+3.9%NT$58.9 million+25.2%
Jun 2026NT$3.4 billion+225.5%NT$55.4 million+41.4%
May 2026NT$2.32 billion+105.8%NT$60.6 million+27.0%
Apr 2026NT$3.09 billion+19.9%NT$68.7 million+66.8%
Mar 2026NT$4.35 billion+173.6%NT$66.7 million+47.1%
Feb 2026NT$2.24 billion+131.5%NT$77.9 million+139.1%
Jan 2026NT$2.05 billion-5.5%NT$53.6 million+37.1%
Dec 2025NT$2.44 billion+66.9%NT$44.1 million+75.0%
Nov 2025NT$1.06 billion-0.2%NT$44.4 million+35.0%
Oct 2025NT$2.75 billion+46.0%NT$43.1 million+47.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16